Rowen Foundation adds Baisiwala to board
Originally published in the Gwinnett Forum.
The Rowen Foundation has named a new director, Ambrish Baisiwala, chairman and CEO of Portman Holdings, to its board. Baisiwala brings more than 30 years of global experience in real estate and international business to the foundation.
Rowen President and CEO Mason Ailstock says:. “His insights, relationships and expertise will accelerate Rowen’s growth as we engage with prospective companies and begin vertical development.”
Baisiwala has held leadership roles in international real estate development and portfolio management across the U.S., China, India, the Middle East, Southeast Asia and Australia.He has led Portman Holdings, an Atlanta-based real estate investment, development, and management firm, for more than 15 years.
Media Coverage
Gwinnett’s bet to build Georgia version of Research Triangle Park starts to pay off
Originally published in The AJC. Belgian biopharmaceutical facility to anchor massive life sciences campus, which still has 1,900 acres to develop. Sometimes envy is the driving force behind economic development. Many states covet the ecosystem created by North Carolina’s Research Triangle Park, a massive biotech and life sciences hub positioned between the Tar Heel State’s […]
Media Coverage
Atlanta’s Suburban Life Sciences Push Gains Traction as UCB Commits $2B to Rowen
Originally published in Globest.com. Rowen, an ambitious project to create a 2,000-acre life sciences park that combines sustainability, environmental protection and advanced manufacturing in a suburban Atlanta county, has scored its first major win. UCB, a global biopharmaceutical company based in Brussels, has announced a $2 billion investment in 79 acres in the Gwinnett County […]
Media Coverage
UCB scoops up 79 acres in Gwinnett County for $2 billion manufacturing plant
Originally published in the Atlanta Business Chronicle. Story Highlights UCB Inc. paid $14.3 million for 79 acres along what used to be known as Old Freeman Mill Road. The Belgium-based pharmaceutical giant plans to develop a $2 billion plant on the Gwinnett County site. It will be part of the planned Rowen life sciences research […]